OLT1177 lowers caspase-1 activity and IL-1 production in monocytes from patients with CAPS, limits adenosine triphosphatase (ATPase) activity, and binds directly to the NLRP3 protein. This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.